BEGIN:VCALENDAR
VERSION:2.0
X-WR-CALNAME:E-Vapor, Nicotine, and Tobacco Law Symposium
METHOD:PUBLISH
BEGIN:VEVENT
UID:1a877753d7fd782c4304180f0523bffd
DTSTAMP:20260518T082403Z
DTSTART:20260504T150000Z
DTEND:20260505T230000
SUMMARY:E-Vapor, Nicotine, and Tobacco Law Symposium
DESCRIPTION: <p><img src="https://cmxmedia.org/public/core_wysiwygphotos/d9/0e/01/aa006933725bcfaba71dad1605d59374.webp" alt="" width="1200" height="300"></p>
<p>Keller and Heckman's E-Vapor, Nicotine, and Tobacco Law Symposium is returning in 2026 for our 10th annual conference. The symposium will be held Monday, May 4 - Tuesday, May 5, 2026, in Las Vegas, NV, right before the CHAMPS Trade Show! This two-day comprehensive seminar is designed to provide in-depth knowledge on legal, regulatory, and scientific issues essential for tobacco, nicotine, and CBD/hemp product manufacturers, suppliers, distributors, and retailers.&nbsp;</p>
<p>Join us in May to hear from our knowledgeable attorneys, scientists, and industry experts who will cover a variety of timely topics, specifically designed to help vapor, oral nicotine, and deemed tobacco product manufacturers stay in compliance with rapidly evolving federal, state, and global laws and policies.</p>
<p>Topics to be discussed include:</p>
<ul>
<li>Update on FDA&rsquo;s New PMTA Guidance for Flavored ENDS</li>
<li>Federal and state regulatory updates for e‑vapor, nicotine, and tobacco products, including PMTA/MRTP pathways and enforcement trends</li>
<li>Litigation developments &ndash; MDO challenges, state enforcement actions, civil penalty disputes, and PMTA directory cases</li>
<li>Distribution and PACT Act enforcement across federal, state, and third‑party actors</li>
<li>Requirements and best practices for setting up U.S. ENDS and oral nicotine manufacturing facilities, including TPMP readiness</li>
<li>Environmental compliance for nicotine product manufacturing</li>
<li>Toxicology and pharmacokinetics considerations for PMTAs involving ENDS and pouches</li>
<li>FDA expectations and common pitfalls in PMTAs for oral nicotine products</li>
<li>Product design strategies to reduce youth appeal and improve likelihood of FDA authorization</li>
<li>Technology‑based youth access prevention systems for ENDS (e.g., SAVE&reg; system)</li>
<li>JUUL‑related PMTA litigation strategy and navigating refusals and denials</li>
<li>Scientific, legal, and policy considerations surrounding nicotine analogs and synthetic nicotine</li>
<li>Rapidly evolving state regulatory frameworks &ndash; flavor bans, PMTA directory laws, oral nicotine regulation, and restrictions on foreign-made products</li>
<li>Updates on California, Canada, the EU/UK, China, and emerging markets</li>
<li>International Trade Commission (ITC) litigation trends reshaping the ENDS market</li>
<li>Hemp, cannabinoids, and cannabis regulation</li>
<li>&hellip;and much more!</li>
</ul>
<p><a href="https://www.khlaw.com/events/2026-e-vapor-nicotine-and-tobacco-law-symposium">https://www.khlaw.com/events/2026-e-vapor-nicotine-and-tobacco-law-symposium</a></p>
<p>&nbsp;</p>
LOCATION:Las Vegas, NV
END:VEVENT
END:VCALENDAR
